Roosevelt Institute | Cornell University

The Expense of Diabetes - The Case for Bundled Payments for Treatment of Diabetes Mellitus Type I

By Jack Viehweg Published January 14, 2022

Diabetes Mellitus Type I is an expensive disease that is increasing in prevalence in the United States. Many patients receive incomplete care due to cost and/or insurance coverage difficulties. Per the lead of other countries, bundled payments for the treatment of this disease could be a way to better tailor diabetic care to each patient, while also reducing healthcare utilization and improving coordination of care.